Time-Restricted Feeding for Critical Illness
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on feeding protocols for critically ill patients.
What data supports the effectiveness of the 12-hour time-restricted feeding (TRF12) treatment for critical illness?
Research on time-restricted feeding (TRF) shows it can help reduce body weight and improve metabolic health markers like cholesterol and blood sugar levels in both animals and humans. These findings suggest that TRF might be beneficial for managing metabolic health, which could be relevant for critical illness.12345
Is time-restricted feeding generally safe for humans?
How does the 12-hour time-restricted feeding treatment differ from other treatments for critical illness?
The 12-hour time-restricted feeding (TRF12) treatment is unique because it involves limiting eating to a specific 12-hour window each day, which is a form of intermittent fasting. This approach is different from traditional treatments for critical illness that may not focus on meal timing and instead emphasize continuous nutrition or specific dietary components.34569
What is the purpose of this trial?
This study is being done to assess the feasibility and safety of a time-restricted 12-hour enteral feeding protocol (experimental group) in comparison to a standard-of-care, 24-hour enteral feeding protocol (control group) in critically ill patients. Investigators hope to gain knowledge about how these feeding schedules affect feeding tolerance, blood sugar control, and other factors affecting critically ill adult patients.* Investigators expect that the 12-hour feeding protocol will be tolerated similarly to the 24-hour feeding protocol and will not result in a greater number of adverse events related to feeding.* Investigators expect that the proportion of participants in both groups receiving at least 75% of their estimated nutrition needs will be similar.
Research Team
Felicia Steger, PhD, MS, RD
Principal Investigator
University of Kansas Medical Center
Eligibility Criteria
This trial is for adults over 18 years old who are critically ill and in an intensive care unit (ICU), with orders to receive continuous enteral nutrition. It's not specified who can't join, but typically those with conditions affecting feeding tolerance or at risk of adverse effects from changes in nutrition might be excluded.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either a 12-hour time-restricted feeding protocol or a 24-hour continuous feeding protocol
Follow-up
Participants are monitored for safety and effectiveness after treatment, including mental health and quality of life assessments
Treatment Details
Interventions
- 12-hour time-restricted feeding (TRF12)
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Kansas Medical Center
Lead Sponsor